ELMO1 and arthritic joint disease: Recent studies have revealed that adenovirus therapy targeting ELMO1 delays the inflammatory response in an arthritis animal model [30], and that the c-terminal helical inhibitory peptide of ELMO1 decreases osteoclast-mediated bone resorption [28].